Literature DB >> 1516827

Ras mediates translation initiation factor 4E-induced malignant transformation.

A Lazaris-Karatzas1, M R Smith, R M Frederickson, M L Jaramillo, Y L Liu, H F Kung, N Sonenberg.   

Abstract

Translation initiation factor eIF-4E binds to the eukaryotic mRNA 5' cap structure (m7 GpppN, where N is any nucleotide). eIF-4E is a limiting factor in translation and plays a key role in regulation of translation. We have shown previously that overexpression of eIF-4E in rodent fibroblasts results in tumorigenic transformation. eIF-4E also exhibits mitogenic activity when microinjected into serum-starved NIH-3T3 cells. To understand the mechanisms by which eIF-4E exerts its mitogenic property, we examined the involvement of the Ras signaling pathway in this activity. Here, we report that Ras is activated in eIF-4E-overexpressing cells, as the proportion of GTP-bound Ras is increased. Overexpression of the negative effector of cellular Ras, GTPase activating protein, causes reversion of the transformed phenotype. Furthermore, we show that neutralizing antibodies to Ras, or a dominant-negative mutant of Ras, inhibit the mitogenic activity of eIF-4E. We conclude that eIF-4E exerts its mitogenic and oncogenic activities by the activation of Ras.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516827     DOI: 10.1101/gad.6.9.1631

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  35 in total

1.  The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Authors:  Ivan Topisirovic; Biljana Culjkovic; Natalie Cohen; Jacqueline M Perez; Lucy Skrabanek; Katherine L B Borden
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 2.  Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis.

Authors:  Sarah Thornton; Nisha Anand; Dan Purcell; Jonathan Lee
Journal:  J Mol Med (Berl)       Date:  2003-08-01       Impact factor: 4.599

3.  Up-regulation of expression of translation factors--a novel molecular mechanism for cadmium carcinogenesis.

Authors:  Pius Joseph; Yi-Xiong Lei; Tong-man Ong
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

4.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 5.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

6.  A new translational regulator with homology to eukaryotic translation initiation factor 4G.

Authors:  H Imataka; H S Olsen; N Sonenberg
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

7.  Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Francisco Vega; L Jeffrey Medeiros; Vasiliki Leventaki; Coralyn Atwell; Jeong Hee Cho-Vega; Ling Tian; Francois-Xavier Claret; George Z Rassidakis
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

8.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Authors:  Lisa M Shantz
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 10.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.